New medicines to improve control and contribute to the eradication of malaria
Top Cited Papers
Open Access
- 16 October 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 8 (11), 879-891
- https://doi.org/10.1038/nrd2972
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsThe Lancet, 2009
- Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparumJournal of Medicinal Chemistry, 2009
- Identification of a Metabolically Stable Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Antimalarial Activity in MiceJournal of Medicinal Chemistry, 2009
- Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trialThe Lancet, 2009
- Structures of Falcipain-2 and Falcipain-3 Bound to Small Molecule Inhibitors: Implications for Substrate SpecificityJournal of Medicinal Chemistry, 2009
- Genomic-scale prioritization of drug targets: the TDR Targets databaseNature Reviews Drug Discovery, 2008
- Comparative genomics of the neglected human malaria parasite Plasmodium vivaxNature, 2008
- Structures of Substrate- and Inhibitor-Bound Adenosine Deaminase from a Human Malaria Parasite Show a Dramatic Conformational Change and Shed Light on Drug SelectivityJournal of Molecular Biology, 2008
- Structural Basis for Selective Inhibition of Mycobacterium tuberculosis Protein Tyrosine Phosphatase PtpBStructure, 2007
- Genome sequence of the human malaria parasite Plasmodium falciparumNature, 2002